New agents in the arsenal to fight castrate-resistant prostate cancer.
about
Antiproliferative 4-(1,2,4-oxadiazol-5-yl)piperidine-1-carboxamides, a new tubulin inhibitor chemotype.Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cellsThe biology of castration-resistant prostate cancerOne-Year Postapproval Clinical Experience with Radium-223 Dichloride in Patients with Metastatic Castrate-Resistant Prostate Cancer.The effects of nonspecific HIF1α inhibitors on development of castrate resistance and metastases in prostate cancer.Chemotherapeutic inhibitors in the treatment of prostate cancer.Bioactive natural products for chemoprevention and treatment of castration-resistant prostate cancer.
P2860
Q30370844-D89FDEA1-23D4-423D-A84B-0F39A05181E6Q34052057-32FBAF81-73D4-42E4-A534-C51C7CBA05B0Q35039889-A07753F3-F9B7-4871-B018-3F1F8F3BCE43Q35822185-8078A7B7-A509-4FCB-A205-9367BDAC2DCAQ37703367-8FA68C7F-0BB5-4028-A34A-582003AAAB07Q38155239-DB92C341-8E34-4A86-AC2C-2312D15082D3Q38883820-7164D1DF-F6BA-4ED8-826C-FD821D6FA45B
P2860
New agents in the arsenal to fight castrate-resistant prostate cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
New agents in the arsenal to fight castrate-resistant prostate cancer.
@en
type
label
New agents in the arsenal to fight castrate-resistant prostate cancer.
@en
prefLabel
New agents in the arsenal to fight castrate-resistant prostate cancer.
@en
P2093
P2860
P1476
New agents in the arsenal to fight castrate-resistant prostate cancer.
@en
P2093
Benjamin J George
Erin E Ezzell
Kuang S Chang
P2860
P2888
P304
P356
10.1007/S11912-013-0305-9
P577
2013-06-01T00:00:00Z
P6179
1050114646